Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Death and EGF[original query] |
---|
Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer. Cancer biology & therapy 2007 Oct 6 (10): 1553-8. Jain Meenu, Kumar Shaleen, Upadhyay Rohit, Lal Puneeta, Tiwari Anu, Ghoshal Uday C, Mittal Balr |
Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population. International journal of colorectal disease 2011 May . Liou JM, Wu MS, Shun CT, Chiu HM, Chen MJ, Chen CC, Wang HP, Lin JT, Liang JT |
High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. Molecular cancer therapeutics 2012 May 11 (5): 1203-13. Levallet Guénaëlle, Bergot Emmanuel, Antoine Martine, Creveuil Christian, Santos Adriana O, Beau-Faller Michelle, de Fraipont Florence, Brambilla Elisabeth, Levallet Jérôme, Morin Franck, Westeel Virginie, Wislez Marie, Quoix Elisabeth, Debieuvre Didier, Dubois Fatéméh, Rouquette Isabelle, Pujol Jean-Louis, Moro-Sibilot Denis, Camonis Jacques, Zalcman Gérard, |
Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
Carcinogenesis 2013 Feb 34 (2): 307-13. Lee Youngjoo, Yoon Kyong-Ah, Joo Jungnam, Lee Donghoon, Bae Kieun, Han Ji-Youn, Lee Jin S |
Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China. Genetic testing and molecular biomarkers 2013 Aug 17 (8): 595-600. Wu Jia, Zhang Wei, Xu Aiqiang, Zhang Li, Yan Tao, Li Zhuo, Wu Xiaopan, Zhu Xilin, Ma Juan, Li Ke, Li Hui, Liu Yi |
Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 827-34. Park Jong Y, Amankwah Ernest K, Anic Gabriella M, Lin Hui-Yi, Walls Brooke, Park Hyun, Krebs Kevin, Madden Melissa, Maddox Kristen, Marzban Suroosh, Fang Shenying, Chen Wei, Lee Jeffrey E, Wei Qingyi, Amos Christopher I, Messina Jane L, Sondak Vernon K, Sellers Thomas A, Egan Kathleen |
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes. BMC cancer 2013 Feb 13 (1): 1. Pentheroudakis G, Kotoula V, De Roock W, Kouvatseas G, Papakostas P, Makatsoris T, Papamichael D, Xanthakis I, Sgouros J, Televantou D, Kafiri G, Tsamandas AC, Razis E, Galani E, Bafaloukos D, Efstratiou I, Bompolaki I, Pectasides D, Pavlidis N, Tejpar S, Fountzilas G |
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Apr 20 (7): 2001-10. Costa Carlota, Molina Miguel Angel, Drozdowskyj Ana, Giménez-Capitán Ana, Bertran-Alamillo Jordi, Karachaliou Niki, Gervais Radj, Massuti Bartomeu, Wei Jia, Moran Teresa, Majem Margarita, Felip Enriqueta, Carcereny Enric, Garcia-Campelo Rosario, Viteri Santiago, Taron Miquel, Ono Mayumi, Giannikopoulos Petros, Bivona Trever, Rosell Rafa |
EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy. OncoTargets and therapy 2014 7 2197-204. Su Nai-Wen, Leu Yi-Shing, Lee Jehn-Chuan, Liu Chung-Ji, Cheng Chieh-Yuan, Lin Jiun-Sheng, Chen Yu-Jen, Chen Chi-Kuan, Fang I-Chih, Hsieh Ruey-Kuen, Chang Yi-Fa |
Pretreatment levels of the serum biomarkers CEA, CYFRA 21-1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients. SpringerPlus 2015 4 171. Romero-Ventosa Elena Yaiza, Blanco-Prieto Sonia, González-Piñeiro Ana Lourdes, Rodríguez-Berrocal Francisco Javier, Piñeiro-Corrales Guadalupe, Páez de la Cadena Mar |
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Jun 10 (6): 910-23. Chen Nan, Fang Wenfeng, Zhan Jianhua, Hong Shaodong, Tang Yanna, Kang Shiyang, Zhang Yaxiong, He Xiaobo, Zhou Ting, Qin Tao, Huang Yan, Yi Xianping, Zhang |
Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival. Cancer biomarkers : section A of Disease markers 2016 Jul . Mehskat Mahboobeh, Tanha Hamzeh Mesrian, Naeini Marjan Mojtabavi, Ghaedi Kamran, Sanati Mohammad H, Meshkat Marzieh, Bagheri Fatem |
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. Clinical transplantation 2016 Feb . Mueller Jessica L, King Lindsay Y, Johnson Kara B, Gao Tian, Nephew Lauren D, Kothari Darshan, Simpson Mary Ann, Zheng Hui, Wei Lan, Corey Kathleen E, Misdraji Joseph, Lee Joon Hyoek, Lin M Valerie, Gogela Neliswa A, Fuchs Bryan C, Tanabe Kenneth K, Gordon Fredric D, Curry Michael P, Chung Raymond |
Association of EGF, IGFBP-3 and TP53 Gene Polymorphisms with Major Depressive Disorder in Slovak Population. Central European journal of public health 2016 Sep 24 (3): 223-230. Mahmood Silvia, Evinová Andrea, Škere?ová Mária, Ondrejka Igor, Lehotský J |
Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome. International journal of molecular sciences 2018 8 19 (8): . Nakamura Hideki, Horai Yoshiro, Shimizu Toshimasa, Kawakami Atsus |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: